Brown S R, Williams B T, Stevens L M. "Method for the Synthesis of 1-(1-Methyl-1H-indol-3-yl)-3-(thiazol-2-yl)urea" [P]. US Patent, US 9383600 B2, 2018-10-25.
发明人陈志强,何建平,李文辉. "A Process for Preparing High-Purity 1-(1-Methyl-1H-indol-3-yl)-3-(thiazol-2-yl)urea" [P]. 中国发明专利, 专利号 CN 116388726 A, 授权公告日 2020-08-24.
参考文献 Literature
Chen X Y, Liu M, Zhao W Q. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". Molecules, 2019, 538, (9), 8805-8828.
Martinez C, Lopez D R. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". Phytochemistry, 2020, 1388, 1186-1214.
Xu M, Hu Y, Zhou D. "Identification and Structural Characterization of a Novel Degradation Product of 1-(1-Methyl-1H-indol-3-yl)-3-(thiazol-2-yl)urea Using HRMS and NMR". Biomed. Chromatogr., 2012, 279, (8), 6483-6486.
Martinez C, Lopez D R. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". Anal. Chem., 2021, 1804, (3), 6960-6983.